Market revenue in 2023 | USD 79.2 million |
Market revenue in 2030 | USD 130.4 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Quantitative |
Fastest growing segment | Digital |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quantitative, Digital, End-point |
Key market players worldwide | Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to real time pcr, digital pcr, and end point pcr market will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 78.66% in 2023. Horizon Databook has segmented the Brazil real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
The Brazil market accounted for the largest share in Latin America due to the increased funding and support for the biotechnology sector by the Government of Brazil (GOB) over the past few years. Around 46% of Brazilians are covered by private insurance companies.
The high healthcare expenditure and the presence of the target population are expected to be the major drivers of this market. In addition, awareness campaigns and premedical checkups are being conducted in Brazil by various nonprofit organizations to monitor the health status of people regularly.
The real-time PCR, digital PCR, and end-point PCR market in Brazil is characterized by dynamic competition and various players. Companies operating in this space face challenges, such as fluctuating demand, regulatory requirements, and pricing pressures.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil real time pcr, digital pcr, and end point pcr market , including forecasts for subscribers. This country databook contains high-level insights into Brazil real time pcr, digital pcr, and end point pcr market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account